Takafumi Okayama

Takafumi Okayama

Auto-generated profile, based on publicly available information

Takafumi Okayama

Department of Surgery, Kitakyushu Municipal Medical Center

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2020 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
TKTakahiro Kinoshita
Takahiro Kinoshita
TOTakafumi Okayama
Takafumi Okayama
Advanced proximal gastric cancer sometimes metastasizes to the splenic hilar lymph nodes (No. 10 LN). Total gastrectomy combined with splenectomy is performed for complete removal of the No. 10 LN and was historically a standard procedure in Japan. However, splenectomy is associated with several disadvantages for patients, such as increased postoperative morbidity, risk of thrombogenic disease, fatal infection from encapsulated bacteria, and the development of other types of cancer in the long term because of loss of immune function. Therefore, splenectomy should only be performed when its estimated oncological effect exceeds such disadvantages. A Japanese randomized controlled trial (JCOG0110) clearly demonstrated that prophylactic splenectomy is not necessary unless the tumor has invaded the greater curvature; thus, splenectomy is no longer routinely performed in Japan. However, several retrospective studies have shown a comparatively high incidence of No. 10 LN metastasis and therapeutic value from LN dissection at that station in the tumors invading the greater curvature. Similar tendencies have also been reported in type 4 or remnant gastric cancer involving the greater curvature. In view of these facts, No. 10 LN dissection is presently recommended for such patients; however, robust evidence is lacking. In recent years, laparoscopic/robotic spleen‐preserving splenic hilar dissection utilizing augmented visualization without pancreatic mobilization has been developed. This procedure is expected to replace prophylactic splenectomy and provide an equal oncological effect with lower morbidity. In Japan, a prospective phase‐II study (JCOG1809) is currently ongoing to investigate the safety and feasibility of this procedure.

1 January 2021 in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Verified
Journal Article
Open access
PDF file
CTChikanori Tsutsumi
Chikanori Tsutsumi
TAToshiya Abe
Toshiya Abe
TOTakafumi Okayama
Takafumi Okayama
HKHirotaka Kuga
Hirotaka Kuga
YSYuzo Shimokawa
Yuzo Shimokawa
TNToru Nakano
Toru Nakano
自己免疫性膵炎(AIP)は限局性病変を形成し,膵癌と鑑別困難な症例が存在する.本検討は当院で経験したAIP 34例を対象とし,その臨床学的因子,手術症例の周術期因子を解析した.AIPの5例(14.7%)で膵癌を疑い,手術を施行した.AIPにおいて,多変量解析でCA19-9高値(>37U/mL)(P=0.01),膵外病変なし(P=0.01),EUS-FNA未施行(P<0.01)が手術施行に関わる独立した因子であった.また,単変量解析で 血管浸潤所見(P=0.03)を認めるAIPで有意に手術が施行され,限局性膵腫大(P=0.06)を認めるAIPで手術が施行される傾向にあった.AIPと膵癌の特徴を同時に認める症例ではそれらの鑑別が困難になりやすく,AIPに対する手術を回避するためにはAIPに特徴的な所見を含め,EUS-FNA/FNBの重要性を再認識する必要があると考えられた.